Skip to content

Phenazocine

NERVOUS SYSTEM

Also known as: fenazocine, phenazocine hydrobromide, phenethylazocine, phenobenzorphan

ATC N02AD02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Phenazocine is a drug catalogued in DrugCentral. DrugCentral lists 5 molecular targets, including OPRM1, OPRK1 and OPRD1.

  • Molecular targets: OPRM1, OPRK1, OPRD1 and Oprm1 (5 listed in DrugCentral).
  • ATC code: N02AD02 (Benzomorphan derivatives).
  • Molecular formula: C22H27NO; molecular weight 321.46 g/mol.

Mechanism & targets

Molecular targets (5)

TargetGeneActionActivity
Mu-type opioid receptorOPRM1unknownKi 9.70
Kappa-type opioid receptorOPRK1unknownKi 8.70
Delta-type opioid receptorOPRD1unknownKi 8.30
Mu-type opioid receptorOprm1unknownIC50 8.10
Mu-type opioid receptorOPRM1unknownIC50 8.01

ATC classification

ATC codeTherapeutic hierarchy
N02AD02NERVOUS SYSTEM › ANALGESICS › OPIOIDS › Benzomorphan derivatives

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Phenazocine is on its molecule page.

Molecular formulaC22H27NO
Molecular weight321.46 g/mol
CAS number127-35-5
InChIKeyZQHYKVKNPWDQSL-UHFFFAOYSA-N
PubChem CID14707
CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CCC1=CC=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Phenazocine work?

Its molecular targets in DrugCentral include OPRM1, OPRK1, OPRD1 and Oprm1.

What is the chemical formula of Phenazocine?

Phenazocine has the molecular formula C22H27NO and a molecular weight of 321.46 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets5
Indications0
FormulaC22H27NO
DrugCentral ID2119
Interactive profile